Laboratory scale-research has shown that a co-culture of geothermal microorganisms (a bacteria and an algae) can consume industrial waste gases carbon dioxide (CO2) and methane (CH4) as a food source for growth. This generates a biomass rich in protein (ca. 60%) that has passed initial toxicity and nutritional testing on mice.
In the next step towards commercialisation, we are optimising operating conditions and improving yields at pilot scale (1,000 L).
We are taking a flexible approach in order to:
The biomass could be used as an animal feed ingredient (biofeedstock), for human nutrition, and, perhaps, to produce high value nutraceuticals or pigments.
We will do the technical development and will evaluate target markets and pathways to these markets, including regulatory requirements and analysis of the techno-economics.
Product-market fit underpins the development of the commercial pathway. We will work to iteratively identify optimal products, markets and price point for maximum value, based on optimisation of the process inputs and assessment of the product-market fit.
We are looking for industry sector partners to test the applicability of this technology for different markets. These essential partners provide insights into product needs, nutritional requirements, competitive options, decarbonisation demands, and market specific regulatory processes.
Contact us to discuss potential alignment and interest.
